According to Ultragenyx Pharmaceutical's latest financial reports the company's current revenue (TTM ) is C$0.87 Billion. In 2024 the company made a revenue of C$0.80 Billion an increase over the revenue in the year 2023 that were of C$0.57 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.